Bluebird Bio Ticks Down On Wider Loss

By: via Benzinga
Bluebird bio Inc (NASDAQ: BLUE) ticked down slightly in Wednesday's extended session after the development-stage drug company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.